naltrexone has been researched along with 3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-isomer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colloc'h, N; Perrio, C; Schmitt, S | 1 |
1 other study(ies) available for naltrexone and 3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-isomer
Article | Year |
---|---|
Novel fluoroalkyl derivatives of selective kappa opioid receptor antagonist JDTic: Design, synthesis, pharmacology and molecular modeling studies.
Topics: Dose-Response Relationship, Drug; Drug Design; Humans; Hydrocarbons, Fluorinated; Models, Molecular; Molecular Structure; Receptors, Opioid, kappa; Structure-Activity Relationship; Tetrahydroisoquinolines | 2015 |